Effects of sodium-glucose co-transporter-2 inhibitors on kidney, cardiovascular, and safety outcomes in patients with advanced chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Effects of sodium-glucose co-transporter-2 inhibitors on kidney, cardiovascular, and safety outcomes in patients with advanced chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials

Published:2022-11-01 Issue:3 Volume:60 Page:325-335
ISSN:1432-5233
Container-title:Acta Diabetologica
language:en
Short-container-title:Acta Diabetol

Author:

Cao Haiyan,Rao Xiaosheng,Jia Junya,Yan Tiekun,Li Dong^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00592-022-01989-7.pdf

Reference43 articles.

1. GBD Chronic Kidney Disease Collaboration (2020) Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 395:709–733. https://doi.org/10.1016/S0140-6736(20)30045-3

2. Foreman KJ, Marquez N, Dolgert A et al (2018) Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet 392:2052–2090. https://doi.org/10.1016/S0140-6736(18)31694-5

3. Hou FF, Zhang X, Zhang GH et al (2006) Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 354:131–140. https://doi.org/10.1056/NEJMoa053107

4. Brenner BM, Cooper ME, de Zeeuw D et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861–869. https://doi.org/10.1056/NEJMoa011161

5. Weir MR, Lakkis JI, Jaar B et al (2018) Use of renin-angiotensin system blockade in advanced CKD: an NKF-KDOQI controversies report. Am J Kidney Dis 72:873–884. https://doi.org/10.1053/j.ajkd.2018.06.010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. La implantación de la cardionefrología en España es una urgencia sanitaria;Nefrología;2024-09

2. Effects of Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic and Non-Diabetic Patients with Advanced Chronic Kidney Disease in Peritoneal Dialysis on Residual Kidney Function: In Real-World Data;Medicina;2024-07-24

3. Long-term trajectory of renal dysfunction and related risk factors in patients with apparently treatment-resistant and non-resistant arterial hypertension;Blood Pressure;2024-06-07

4. Associations Between Sodium-Glucose Co-transporter 2 Inhibitors and Urologic Diseases: Implications for Lower Urinary Tract Symptoms From a Multi-State Health System Analysis;Urology;2024-06

5. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes;Cochrane Database of Systematic Reviews;2024-05-21